UniProt ID | PUF60_HUMAN | |
---|---|---|
UniProt AC | Q9UHX1 | |
Protein Name | Poly(U)-binding-splicing factor PUF60 | |
Gene Name | PUF60 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 559 | |
Subcellular Localization | Nucleus . Colocalizes partially with TROVE2. | |
Protein Description | DNA- and RNA-binding protein, involved in several nuclear processes such as pre-mRNA splicing, apoptosis and transcription regulation. In association with FUBP1 regulates MYC transcription at the P2 promoter through the core-TFIIH basal transcription factor. Acts as a transcriptional repressor through the core-TFIIH basal transcription factor. Represses FUBP1-induced transcriptional activation but not basal transcription. Decreases ERCC3 helicase activity. Does not repress TFIIH-mediated transcription in xeroderma pigmentosum complementation group B (XPB) cells. Is also involved in pre-mRNA splicing. Promotes splicing of an intron with weak 3'-splice site and pyrimidine tract in a cooperative manner with U2AF2. Involved in apoptosis induction when overexpressed in HeLa cells. Isoform 6 failed to repress MYC transcription and inhibited FIR-induced apoptosis in colorectal cancer. Isoform 6 may contribute to tumor progression by enabling increased MYC expression and greater resistance to apoptosis in tumors than in normal cells. Modulates alternative splicing of several mRNAs. Binds to relaxed DNA of active promoter regions. Binds to the pyrimidine tract and 3'-splice site regions of pre-mRNA; binding is enhanced in presence of U2AF2. Binds to Y5 RNA in association with TROVE2. Binds to poly(U) RNA.. | |
Protein Sequence | MATATIALQVNGQQGGGSEPAAAAAVVAAGDKWKPPQGTDSIKMENGQSTAAKLGLPPLTPEQQEALQKAKKYAMEQSIKSVLVKQTIAHQQQQLTNLQMAAVTMGFGDPLSPLQSMAAQRQRALAIMCRVYVGSIYYELGEDTIRQAFAPFGPIKSIDMSWDSVTMKHKGFAFVEYEVPEAAQLALEQMNSVMLGGRNIKVGRPSNIGQAQPIIDQLAEEARAFNRIYVASVHQDLSDDDIKSVFEAFGKIKSCTLARDPTTGKHKGYGFIEYEKAQSSQDAVSSMNLFDLGGQYLRVGKAVTPPMPLLTPATPGGLPPAAAVAAAAATAKITAQEAVAGAAVLGTLGTPGLVSPALTLAQPLGTLPQAVMAAQAPGVITGVTPARPPIPVTIPSVGVVNPILASPPTLGLLEPKKEKEEEELFPESERPEMLSEQEHMSISGSSARHMVMQKLLRKQESTVMVLRNMVDPKDIDDDLEGEVTEECGKFGAVNRVIIYQEKQGEEEDAEIIVKIFVEFSIASETHKAIQALNGRWFAGRKVVAEVYDQERFDNSDLSA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MATATIALQV -----CCEEEEEEEE | 24.04 | 18491316 | |
3 (in isoform 2) | Phosphorylation | - | 24.04 | - | |
3 (in isoform 5) | Phosphorylation | - | 24.04 | 20860994 | |
3 (in isoform 6) | Phosphorylation | - | 24.04 | 20860994 | |
5 | Phosphorylation | ---MATATIALQVNG ---CCEEEEEEEECC | 11.48 | 18491316 | |
5 (in isoform 5) | Phosphorylation | - | 11.48 | 20860994 | |
5 (in isoform 6) | Phosphorylation | - | 11.48 | 20860994 | |
10 (in isoform 5) | Phosphorylation | - | 10.13 | 20860994 | |
10 (in isoform 6) | Phosphorylation | - | 10.13 | 20860994 | |
12 (in isoform 5) | Phosphorylation | - | 23.49 | 21406692 | |
12 (in isoform 6) | Phosphorylation | - | 23.49 | 21406692 | |
14 (in isoform 5) | Sumoylation | - | 54.63 | - | |
14 (in isoform 6) | Sumoylation | - | 54.63 | - | |
18 | Phosphorylation | NGQQGGGSEPAAAAA CCCCCCCCCHHHHHH | 43.62 | 25867546 | |
26 | Ubiquitination | EPAAAAAVVAAGDKW CHHHHHHHHHCCCCC | 2.30 | 29967540 | |
29 | Ubiquitination | AAAAVVAAGDKWKPP HHHHHHHCCCCCCCC | 18.33 | 29967540 | |
33 | Ubiquitination | VVAAGDKWKPPQGTD HHHCCCCCCCCCCCC | 24.11 | 29967540 | |
34 | Ubiquitination | VAAGDKWKPPQGTDS HHCCCCCCCCCCCCC | 53.19 | 29967540 | |
37 | Ubiquitination | GDKWKPPQGTDSIKM CCCCCCCCCCCCEEE | 75.77 | 23000965 | |
37 (in isoform 3) | Ubiquitination | - | 75.77 | 21890473 | |
37 (in isoform 4) | Ubiquitination | - | 75.77 | 21890473 | |
40 | Ubiquitination | WKPPQGTDSIKMENG CCCCCCCCCEEEECC | 56.01 | 29967540 | |
41 | Phosphorylation | KPPQGTDSIKMENGQ CCCCCCCCEEEECCC | 24.77 | 25627689 | |
42 | Ubiquitination | PPQGTDSIKMENGQS CCCCCCCEEEECCCC | 5.69 | 23000965 | |
43 | Sumoylation | PQGTDSIKMENGQST CCCCCCEEEECCCCH | 44.08 | - | |
43 | Sumoylation | PQGTDSIKMENGQST CCCCCCEEEECCCCH | 44.08 | 28112733 | |
43 | Ubiquitination | PQGTDSIKMENGQST CCCCCCEEEECCCCH | 44.08 | 29967540 | |
44 (in isoform 4) | Phosphorylation | - | 4.63 | 27251275 | |
51 | Ubiquitination | MENGQSTAAKLGLPP EECCCCHHHHHCCCC | 14.08 | 23000965 | |
51 (in isoform 5) | Ubiquitination | - | 14.08 | 21890473 | |
51 (in isoform 6) | Ubiquitination | - | 14.08 | 21890473 | |
56 | Ubiquitination | STAAKLGLPPLTPEQ CHHHHHCCCCCCHHH | 5.98 | 23000965 | |
58 (in isoform 6) | Phosphorylation | - | 54.64 | 27251275 | |
60 | Phosphorylation | KLGLPPLTPEQQEAL HHCCCCCCHHHHHHH | 30.47 | 30266825 | |
60 (in isoform 2) | Phosphorylation | - | 30.47 | - | |
68 | Ubiquitination | PEQQEALQKAKKYAM HHHHHHHHHHHHHHH | 51.19 | 29967540 | |
69 | Acetylation | EQQEALQKAKKYAME HHHHHHHHHHHHHHH | 64.12 | 26051181 | |
69 | Ubiquitination | EQQEALQKAKKYAME HHHHHHHHHHHHHHH | 64.12 | 29967540 | |
71 | Ubiquitination | QEALQKAKKYAMEQS HHHHHHHHHHHHHHH | 54.04 | 29967540 | |
72 | 2-Hydroxyisobutyrylation | EALQKAKKYAMEQSI HHHHHHHHHHHHHHH | 43.00 | - | |
72 | Acetylation | EALQKAKKYAMEQSI HHHHHHHHHHHHHHH | 43.00 | 27452117 | |
72 | Methylation | EALQKAKKYAMEQSI HHHHHHHHHHHHHHH | 43.00 | - | |
72 | Ubiquitination | EALQKAKKYAMEQSI HHHHHHHHHHHHHHH | 43.00 | 29967540 | |
73 | Phosphorylation | ALQKAKKYAMEQSIK HHHHHHHHHHHHHHH | 15.52 | 28509920 | |
78 | Phosphorylation | KKYAMEQSIKSVLVK HHHHHHHHHHHHHHH | 20.76 | 29978859 | |
79 | Ubiquitination | KYAMEQSIKSVLVKQ HHHHHHHHHHHHHHH | 3.73 | 23000965 | |
80 | Sumoylation | YAMEQSIKSVLVKQT HHHHHHHHHHHHHHH | 39.50 | 28112733 | |
80 | Ubiquitination | YAMEQSIKSVLVKQT HHHHHHHHHHHHHHH | 39.50 | 23000965 | |
80 (in isoform 1) | Ubiquitination | - | 39.50 | 21890473 | |
80 (in isoform 2) | Ubiquitination | - | 39.50 | 21890473 | |
81 | Phosphorylation | AMEQSIKSVLVKQTI HHHHHHHHHHHHHHH | 21.00 | 20860994 | |
84 | Ubiquitination | QSIKSVLVKQTIAHQ HHHHHHHHHHHHHHH | 3.96 | 23000965 | |
85 | Ubiquitination | SIKSVLVKQTIAHQQ HHHHHHHHHHHHHHH | 37.25 | 23000965 | |
87 | Phosphorylation | KSVLVKQTIAHQQQQ HHHHHHHHHHHHHHH | 17.89 | 24043423 | |
87 (in isoform 2) | Phosphorylation | - | 17.89 | 27251275 | |
96 | Phosphorylation | AHQQQQLTNLQMAAV HHHHHHHHHHHHHHH | 29.55 | 24043423 | |
104 | Phosphorylation | NLQMAAVTMGFGDPL HHHHHHHHCCCCCCC | 13.57 | 28102081 | |
105 | Ubiquitination | LQMAAVTMGFGDPLS HHHHHHHCCCCCCCC | 3.17 | 23000965 | |
108 | Ubiquitination | AAVTMGFGDPLSPLQ HHHHCCCCCCCCHHH | 29.87 | 29967540 | |
110 | Ubiquitination | VTMGFGDPLSPLQSM HHCCCCCCCCHHHHH | 34.81 | 23000965 | |
112 | Phosphorylation | MGFGDPLSPLQSMAA CCCCCCCCHHHHHHH | 29.02 | 20068231 | |
116 | Phosphorylation | DPLSPLQSMAAQRQR CCCCHHHHHHHHHHH | 20.33 | 24043423 | |
117 | Ubiquitination | PLSPLQSMAAQRQRA CCCHHHHHHHHHHHH | 2.00 | 23000965 | |
122 | Ubiquitination | QSMAAQRQRALAIMC HHHHHHHHHHHHHHH | 23.95 | 23000965 | |
125 | Ubiquitination | AAQRQRALAIMCRVY HHHHHHHHHHHHHHH | 3.46 | 29967540 | |
139 | Ubiquitination | YVGSIYYELGEDTIR HHHHHHHHCCCCHHH | 33.07 | 29967540 | |
150 | Ubiquitination | DTIRQAFAPFGPIKS CHHHHHHCCCCCCEE | 11.09 | 29967540 | |
151 | Ubiquitination | TIRQAFAPFGPIKSI HHHHHHCCCCCCEEE | 28.42 | 29967540 | |
157 | Phosphorylation | APFGPIKSIDMSWDS CCCCCCEEEECCCCC | 25.25 | 21601212 | |
167 | Ubiquitination | MSWDSVTMKHKGFAF CCCCCEEECCCCEEE | 3.92 | 29967540 | |
168 | Ubiquitination | SWDSVTMKHKGFAFV CCCCEEECCCCEEEE | 32.57 | 29967540 | |
172 (in isoform 5) | Ubiquitination | - | 5.94 | - | |
177 | Phosphorylation | KGFAFVEYEVPEAAQ CCEEEEEEECHHHHH | 19.54 | - | |
183 | Ubiquitination | EYEVPEAAQLALEQM EEECHHHHHHHHHHH | 11.85 | 21963094 | |
189 (in isoform 2) | Phosphorylation | - | 36.89 | - | |
191 | Acetylation | QLALEQMNSVMLGGR HHHHHHHHCCEECCC | 31.01 | 19608861 | |
191 | Ubiquitination | QLALEQMNSVMLGGR HHHHHHHHCCEECCC | 31.01 | 33845483 | |
191 (in isoform 4) | Ubiquitination | - | 31.01 | 21890473 | |
197 | Ubiquitination | MNSVMLGGRNIKVGR HHCCEECCCCCCCCC | 18.59 | 21963094 | |
200 | Ubiquitination | VMLGGRNIKVGRPSN CEECCCCCCCCCCCC | 3.54 | 21963094 | |
201 | Acetylation | MLGGRNIKVGRPSNI EECCCCCCCCCCCCC | 42.03 | 25953088 | |
201 | Ubiquitination | MLGGRNIKVGRPSNI EECCCCCCCCCCCCC | 42.03 | - | |
205 | Acetylation | RNIKVGRPSNIGQAQ CCCCCCCCCCCCCCH | 26.29 | 19608861 | |
205 | Ubiquitination | RNIKVGRPSNIGQAQ CCCCCCCCCCCCCCH | 26.29 | 33845483 | |
205 (in isoform 6) | Ubiquitination | - | 26.29 | 21890473 | |
206 | Phosphorylation | NIKVGRPSNIGQAQP CCCCCCCCCCCCCHH | 39.45 | 25159151 | |
207 | Ubiquitination | IKVGRPSNIGQAQPI CCCCCCCCCCCCHHH | 45.13 | 33845483 | |
208 | Acetylation | KVGRPSNIGQAQPII CCCCCCCCCCCHHHH | 5.19 | 19608861 | |
208 | Ubiquitination | KVGRPSNIGQAQPII CCCCCCCCCCCHHHH | 5.19 | 33845483 | |
208 (in isoform 3) | Ubiquitination | - | 5.19 | 21890473 | |
214 | Ubiquitination | NIGQAQPIIDQLAEE CCCCCHHHHHHHHHH | 3.45 | 21963094 | |
214 (in isoform 5) | Ubiquitination | - | 3.45 | - | |
219 | Ubiquitination | QPIIDQLAEEARAFN HHHHHHHHHHHHHHC | 13.62 | 23503661 | |
221 | Ubiquitination | IIDQLAEEARAFNRI HHHHHHHHHHHHCCE | 37.54 | 33845483 | |
222 | Acetylation | IDQLAEEARAFNRIY HHHHHHHHHHHCCEE | 10.29 | 19608861 | |
222 | Ubiquitination | IDQLAEEARAFNRIY HHHHHHHHHHHCCEE | 10.29 | 33845483 | |
222 (in isoform 5) | Ubiquitination | - | 10.29 | 21890473 | |
224 | Ubiquitination | QLAEEARAFNRIYVA HHHHHHHHHCCEEEE | 17.08 | 33845483 | |
224 (in isoform 5) | Ubiquitination | - | 17.08 | - | |
225 | Ubiquitination | LAEEARAFNRIYVAS HHHHHHHHCCEEEEE | 5.42 | 21963094 | |
226 | Ubiquitination | AEEARAFNRIYVASV HHHHHHHCCEEEEEE | 28.58 | 21963094 | |
226 (in isoform 2) | Ubiquitination | - | 28.58 | - | |
227 (in isoform 2) | Phosphorylation | - | 18.37 | 21406692 | |
232 | Phosphorylation | FNRIYVASVHQDLSD HCCEEEEEECCCCCH | 15.30 | 20873877 | |
233 | Acetylation | NRIYVASVHQDLSDD CCEEEEEECCCCCHH | 3.20 | 19608861 | |
233 | Ubiquitination | NRIYVASVHQDLSDD CCEEEEEECCCCCHH | 3.20 | 33845483 | |
234 | Acetylation | RIYVASVHQDLSDDD CEEEEEECCCCCHHH | 16.97 | 19608861 | |
234 | Ubiquitination | RIYVASVHQDLSDDD CEEEEEECCCCCHHH | 16.97 | 33845483 | |
234 (in isoform 2) | Acetylation | - | 16.97 | - | |
234 (in isoform 2) | Ubiquitination | - | 16.97 | 21890473 | |
236 | Ubiquitination | YVASVHQDLSDDDIK EEEEECCCCCHHHHH | 33.01 | 23503661 | |
238 | Phosphorylation | ASVHQDLSDDDIKSV EEECCCCCHHHHHHH | 47.48 | 20873877 | |
238 | Ubiquitination | ASVHQDLSDDDIKSV EEECCCCCHHHHHHH | 47.48 | 33845483 | |
238 (in isoform 5) | Ubiquitination | - | 47.48 | - | |
241 | Ubiquitination | HQDLSDDDIKSVFEA CCCCCHHHHHHHHHH | 56.03 | 21963094 | |
242 | Ubiquitination | QDLSDDDIKSVFEAF CCCCHHHHHHHHHHH | 4.63 | 21963094 | |
243 | Acetylation | DLSDDDIKSVFEAFG CCCHHHHHHHHHHHH | 47.78 | 26051181 | |
243 | Ubiquitination | DLSDDDIKSVFEAFG CCCHHHHHHHHHHHH | 47.78 | 21963094 | |
244 | Phosphorylation | LSDDDIKSVFEAFGK CCHHHHHHHHHHHHC | 32.16 | 30266825 | |
247 | Ubiquitination | DDIKSVFEAFGKIKS HHHHHHHHHHHCCEE | 40.72 | 23503661 | |
248 | Ubiquitination | DIKSVFEAFGKIKSC HHHHHHHHHHCCEEE | 13.66 | 23503661 | |
249 | Ubiquitination | IKSVFEAFGKIKSCT HHHHHHHHHCCEEEE | 8.90 | 33845483 | |
250 | Acetylation | KSVFEAFGKIKSCTL HHHHHHHHCCEEEEE | 37.51 | 19608861 | |
250 | Ubiquitination | KSVFEAFGKIKSCTL HHHHHHHHCCEEEEE | 37.51 | 33845483 | |
250 (in isoform 2) | Ubiquitination | - | 37.51 | - | |
251 | Acetylation | SVFEAFGKIKSCTLA HHHHHHHCCEEEEEE | 40.27 | 19608861 | |
251 | Ubiquitination | SVFEAFGKIKSCTLA HHHHHHHCCEEEEEE | 40.27 | 33845483 | |
251 (in isoform 1) | Ubiquitination | - | 40.27 | 21890473 | |
255 | Ubiquitination | AFGKIKSCTLARDPT HHHCCEEEEEEECCC | 2.84 | 21963094 | |
258 | Ubiquitination | KIKSCTLARDPTTGK CCEEEEEEECCCCCC | 8.83 | 21963094 | |
262 | Phosphorylation | CTLARDPTTGKHKGY EEEEECCCCCCCCCC | 53.09 | - | |
263 | Phosphorylation | TLARDPTTGKHKGYG EEEECCCCCCCCCCC | 50.01 | - | |
263 | Ubiquitination | TLARDPTTGKHKGYG EEEECCCCCCCCCCC | 50.01 | 21963094 | |
264 | Ubiquitination | LARDPTTGKHKGYGF EEECCCCCCCCCCCE | 32.33 | 23503661 | |
265 | Ubiquitination | ARDPTTGKHKGYGFI EECCCCCCCCCCCEE | 39.80 | 23503661 | |
266 | Ubiquitination | RDPTTGKHKGYGFIE ECCCCCCCCCCCEEE | 30.07 | 33845483 | |
267 | Acetylation | DPTTGKHKGYGFIEY CCCCCCCCCCCEEEE | 58.26 | 26051181 | |
267 | Ubiquitination | DPTTGKHKGYGFIEY CCCCCCCCCCCEEEE | 58.26 | 33845483 | |
268 | Ubiquitination | PTTGKHKGYGFIEYE CCCCCCCCCCEEEEE | 27.76 | 21963094 | |
269 | Phosphorylation | TTGKHKGYGFIEYEK CCCCCCCCCEEEEEE | 17.42 | 24043423 | |
271 | Ubiquitination | GKHKGYGFIEYEKAQ CCCCCCCEEEEEECC | 2.63 | 21890473 | |
272 | Ubiquitination | KHKGYGFIEYEKAQS CCCCCCEEEEEECCC | 4.84 | 21963094 | |
274 | Phosphorylation | KGYGFIEYEKAQSSQ CCCCEEEEEECCCCC | 20.22 | 24043423 | |
276 | Ubiquitination | YGFIEYEKAQSSQDA CCEEEEEECCCCCHH | 51.31 | 21890473 | |
279 | Phosphorylation | IEYEKAQSSQDAVSS EEEEECCCCCHHHHH | 34.52 | 21712546 | |
280 | Phosphorylation | EYEKAQSSQDAVSSM EEEECCCCCHHHHHC | 21.72 | 21712546 | |
280 | Ubiquitination | EYEKAQSSQDAVSSM EEEECCCCCHHHHHC | 21.72 | 21963094 | |
283 | Ubiquitination | KAQSSQDAVSSMNLF ECCCCCHHHHHCCHH | 8.75 | 21963094 | |
284 | Ubiquitination | AQSSQDAVSSMNLFD CCCCCHHHHHCCHHH | 6.15 | 21963094 | |
284 (in isoform 2) | Ubiquitination | - | 6.15 | - | |
285 | Phosphorylation | QSSQDAVSSMNLFDL CCCCHHHHHCCHHHC | 26.12 | 24043423 | |
285 | Ubiquitination | QSSQDAVSSMNLFDL CCCCHHHHHCCHHHC | 26.12 | 23503661 | |
286 | Phosphorylation | SSQDAVSSMNLFDLG CCCHHHHHCCHHHCC | 12.70 | 24043423 | |
287 | Ubiquitination | SQDAVSSMNLFDLGG CCHHHHHCCHHHCCC | 3.83 | 33845483 | |
288 | Ubiquitination | QDAVSSMNLFDLGGQ CHHHHHCCHHHCCCC | 39.23 | 21890473 | |
290 | Ubiquitination | AVSSMNLFDLGGQYL HHHHCCHHHCCCCEE | 6.56 | 23503661 | |
292 | Ubiquitination | SSMNLFDLGGQYLRV HHCCHHHCCCCEEEE | 6.95 | 23503661 | |
294 (in isoform 2) | Phosphorylation | - | 21.91 | - | |
296 | Phosphorylation | LFDLGGQYLRVGKAV HHHCCCCEEEEECCC | 10.35 | 24043423 | |
297 (in isoform 2) | Phosphorylation | - | 2.48 | - | |
300 | Ubiquitination | GGQYLRVGKAVTPPM CCCEEEEECCCCCCC | 13.03 | 21963094 | |
301 | Ubiquitination | GQYLRVGKAVTPPMP CCEEEEECCCCCCCC | 36.51 | 21963094 | |
302 | Ubiquitination | QYLRVGKAVTPPMPL CEEEEECCCCCCCCC | 12.42 | 23503661 | |
304 | Phosphorylation | LRVGKAVTPPMPLLT EEEECCCCCCCCCCC | 26.91 | 20068231 | |
304 | Ubiquitination | LRVGKAVTPPMPLLT EEEECCCCCCCCCCC | 26.91 | 33845483 | |
307 | Sulfoxidation | GKAVTPPMPLLTPAT ECCCCCCCCCCCCCC | 3.72 | 21406390 | |
311 | Phosphorylation | TPPMPLLTPATPGGL CCCCCCCCCCCCCCC | 20.68 | 28674151 | |
314 | Phosphorylation | MPLLTPATPGGLPPA CCCCCCCCCCCCCHH | 24.54 | 28355574 | |
321 | Ubiquitination | TPGGLPPAAAVAAAA CCCCCCHHHHHHHHH | 13.20 | 21963094 | |
326 | Ubiquitination | PPAAAVAAAAATAKI CHHHHHHHHHHHCCC | 7.34 | 21963094 | |
330 | Phosphorylation | AVAAAAATAKITAQE HHHHHHHHCCCCHHH | 24.61 | 26552605 | |
338 | Ubiquitination | AKITAQEAVAGAAVL CCCCHHHHHHHHHHH | 5.60 | 21963094 | |
350 | Phosphorylation | AVLGTLGTPGLVSPA HHHHCCCCCCCCCHH | 19.80 | 26853621 | |
355 | Phosphorylation | LGTPGLVSPALTLAQ CCCCCCCCHHHHHHC | 14.97 | 26074081 | |
359 | Phosphorylation | GLVSPALTLAQPLGT CCCCHHHHHHCCCCC | 23.35 | 26074081 | |
389 (in isoform 2) | Phosphorylation | - | 37.65 | - | |
394 | Acetylation | RPPIPVTIPSVGVVN CCCCCCCCCCCCCCC | 2.14 | 19608861 | |
394 | Ubiquitination | RPPIPVTIPSVGVVN CCCCCCCCCCCCCCC | 2.14 | 23000965 | |
398 | Ubiquitination | PVTIPSVGVVNPILA CCCCCCCCCCCHHHC | 23.22 | 23000965 | |
406 | O-linked_Glycosylation | VVNPILASPPTLGLL CCCHHHCCCCCCCCC | 28.15 | OGP | |
406 | Phosphorylation | VVNPILASPPTLGLL CCCHHHCCCCCCCCC | 28.15 | 20058876 | |
408 | Acetylation | NPILASPPTLGLLEP CHHHCCCCCCCCCCC | 37.45 | 19608861 | |
408 | Ubiquitination | NPILASPPTLGLLEP CHHHCCCCCCCCCCC | 37.45 | 23000965 | |
411 | Acetylation | LASPPTLGLLEPKKE HCCCCCCCCCCCCCH | 30.60 | 19608861 | |
411 | Ubiquitination | LASPPTLGLLEPKKE HCCCCCCCCCCCCCH | 30.60 | 23000965 | |
412 | Ubiquitination | ASPPTLGLLEPKKEK CCCCCCCCCCCCCHH | 5.72 | 23000965 | |
415 | Ubiquitination | PTLGLLEPKKEKEEE CCCCCCCCCCHHHHH | 53.65 | 23000965 | |
419 | Sumoylation | LLEPKKEKEEEELFP CCCCCCHHHHHHHCC | 78.34 | 28112733 | |
425 | Acetylation | EKEEEELFPESERPE HHHHHHHCCCCCCHH | 7.74 | 19608861 | |
425 | Ubiquitination | EKEEEELFPESERPE HHHHHHHCCCCCCHH | 7.74 | 23000965 | |
428 | Phosphorylation | EEELFPESERPEMLS HHHHCCCCCCHHHCC | 38.86 | 30108239 | |
429 | Ubiquitination | EELFPESERPEMLSE HHHCCCCCCHHHCCC | 71.27 | 23000965 | |
435 | Phosphorylation | SERPEMLSEQEHMSI CCCHHHCCCCCCCCC | 35.60 | 30108239 | |
436 | Acetylation | ERPEMLSEQEHMSIS CCHHHCCCCCCCCCC | 56.90 | 19608861 | |
436 | Ubiquitination | ERPEMLSEQEHMSIS CCHHHCCCCCCCCCC | 56.90 | 23000965 | |
437 | Acetylation | RPEMLSEQEHMSISG CHHHCCCCCCCCCCH | 42.38 | 19608861 | |
437 | Ubiquitination | RPEMLSEQEHMSISG CHHHCCCCCCCCCCH | 42.38 | 23000965 | |
437 (in isoform 2) | Acetylation | - | 42.38 | - | |
440 | Ubiquitination | MLSEQEHMSISGSSA HCCCCCCCCCCHHHH | 3.61 | 23000965 | |
441 | Phosphorylation | LSEQEHMSISGSSAR CCCCCCCCCCHHHHH | 18.60 | 30108239 | |
441 | Ubiquitination | LSEQEHMSISGSSAR CCCCCCCCCCHHHHH | 18.60 | 23000965 | |
443 | Phosphorylation | EQEHMSISGSSARHM CCCCCCCCHHHHHHH | 25.89 | 30108239 | |
443 | Ubiquitination | EQEHMSISGSSARHM CCCCCCCCHHHHHHH | 25.89 | 24816145 | |
445 | Phosphorylation | EHMSISGSSARHMVM CCCCCCHHHHHHHHH | 17.65 | 30108239 | |
446 | Phosphorylation | HMSISGSSARHMVMQ CCCCCHHHHHHHHHH | 32.61 | 30108239 | |
446 | Ubiquitination | HMSISGSSARHMVMQ CCCCCHHHHHHHHHH | 32.61 | 24816145 | |
453 | Acetylation | SARHMVMQKLLRKQE HHHHHHHHHHHHCCH | 23.10 | 19608861 | |
453 | Ubiquitination | SARHMVMQKLLRKQE HHHHHHHHHHHHCCH | 23.10 | 23000965 | |
454 | Acetylation | ARHMVMQKLLRKQES HHHHHHHHHHHCCHH | 31.24 | 19608861 | |
454 | Ubiquitination | ARHMVMQKLLRKQES HHHHHHHHHHHCCHH | 31.24 | 23000965 | |
457 | Ubiquitination | MVMQKLLRKQESTVM HHHHHHHHCCHHHHE | 49.39 | 23000965 | |
458 | Sumoylation | VMQKLLRKQESTVMV HHHHHHHCCHHHHEE | 59.39 | - | |
458 | 2-Hydroxyisobutyrylation | VMQKLLRKQESTVMV HHHHHHHCCHHHHEE | 59.39 | - | |
458 | Sumoylation | VMQKLLRKQESTVMV HHHHHHHCCHHHHEE | 59.39 | 28112733 | |
458 | Ubiquitination | VMQKLLRKQESTVMV HHHHHHHCCHHHHEE | 59.39 | 23000965 | |
460 | Ubiquitination | QKLLRKQESTVMVLR HHHHHCCHHHHEEEE | 51.95 | 24816145 | |
461 | Phosphorylation | KLLRKQESTVMVLRN HHHHCCHHHHEEEEC | 24.65 | 30624053 | |
462 | Phosphorylation | LLRKQESTVMVLRNM HHHCCHHHHEEEECC | 16.33 | 23403867 | |
471 | Ubiquitination | MVLRNMVDPKDIDDD EEEECCCCHHHCCCC | 33.49 | 24816145 | |
472 | Ubiquitination | VLRNMVDPKDIDDDL EEECCCCHHHCCCCC | 25.47 | 24816145 | |
473 | Acetylation | LRNMVDPKDIDDDLE EECCCCHHHCCCCCC | 63.95 | 26051181 | |
474 | Ubiquitination | RNMVDPKDIDDDLEG ECCCCHHHCCCCCCC | 55.74 | 23000965 | |
478 | Ubiquitination | DPKDIDDDLEGEVTE CHHHCCCCCCCCCHH | 42.76 | 23000965 | |
479 | Ubiquitination | PKDIDDDLEGEVTEE HHHCCCCCCCCCHHH | 13.49 | 23000965 | |
481 | Ubiquitination | DIDDDLEGEVTEECG HCCCCCCCCCHHHHH | 41.81 | 24816145 | |
483 | Ubiquitination | DDDLEGEVTEECGKF CCCCCCCCHHHHHCC | 13.85 | 23000965 | |
488 | Ubiquitination | GEVTEECGKFGAVNR CCCHHHHHCCCCEEE | 31.44 | 24816145 | |
489 | Acetylation | EVTEECGKFGAVNRV CCHHHHHCCCCEEEE | 52.89 | 26051181 | |
489 | Ubiquitination | EVTEECGKFGAVNRV CCHHHHHCCCCEEEE | 52.89 | 24816145 | |
491 | Ubiquitination | TEECGKFGAVNRVII HHHHHCCCCEEEEEE | 31.91 | 23000965 | |
495 | Ubiquitination | GKFGAVNRVIIYQEK HCCCCEEEEEEEECC | 17.89 | 23000965 | |
498 | Ubiquitination | GAVNRVIIYQEKQGE CCEEEEEEEECCCCC | 2.38 | 24816145 | |
509 | Ubiquitination | KQGEEEDAEIIVKIF CCCCHHCHHHHHHHH | 17.11 | 24816145 | |
512 | Ubiquitination | EEEDAEIIVKIFVEF CHHCHHHHHHHHHEE | 1.62 | 24816145 | |
514 | Ubiquitination | EDAEIIVKIFVEFSI HCHHHHHHHHHEEEE | 21.73 | 24816145 | |
523 | Ubiquitination | FVEFSIASETHKAIQ HHEEEECCCHHHHHH | 41.16 | 24816145 | |
524 | Ubiquitination | VEFSIASETHKAIQA HEEEECCCHHHHHHH | 46.00 | 24816145 | |
524 (in isoform 2) | Malonylation | - | 46.00 | 32601280 | |
526 | Ubiquitination | FSIASETHKAIQALN EEECCCHHHHHHHHC | 17.31 | 24816145 | |
540 | Ubiquitination | NGRWFAGRKVVAEVY CCCCCCCCEEEEEEE | 25.76 | 24816145 | |
541 | 2-Hydroxyisobutyrylation | GRWFAGRKVVAEVYD CCCCCCCEEEEEEEC | 39.89 | - | |
541 | Ubiquitination | GRWFAGRKVVAEVYD CCCCCCCEEEEEEEC | 39.89 | 24816145 | |
547 | Phosphorylation | RKVVAEVYDQERFDN CEEEEEEECHHHCCC | 11.92 | - | |
555 | Phosphorylation | DQERFDNSDLSA--- CHHHCCCCCCCC--- | 41.60 | 26462736 | |
558 | Phosphorylation | RFDNSDLSA------ HCCCCCCCC------ | 36.60 | 30108239 | |
561 | Ubiquitination | NSDLSA--------- CCCCCC--------- | 24816145 | ||
566 | Ubiquitination | A-------------- C-------------- | 24816145 | ||
578 | Ubiquitination | -------------------------- -------------------------- | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PUF60_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PUF60_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PUF60_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615583 | Verheij syndrome (VRJS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-251 AND LYS-454, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-60 AND SER-206, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-60, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-60, AND MASSSPECTROMETRY. |